US biotech company Mirati Therapeutics announced positive Phase II results for its investigational treatment adagrasib as a treatment for KRAS-mutated lung cancer. The Phase II …
IPI was established by professionals with over 30 years of experience in the Pharmaceutical and Life sciences publishing sectors. Peer-Reviewed, Contemporary, Authoritative
